including retail, media, manufacturing and pharmaceuticals, Cortexica’s technology is robust and flexible and can be integrated to any requirements on any system or platform, including on device. The ability to partner with clients to create AI solutions for their specific needs, from innovation to delivery, ensures maximum benefit and return on investment.  

Cortexica was developed from the Bioengineering Department of Imperial College London, and originated from a pioneering research to reverse-engineer the human visual cortex.